V009-3925 Screening compound: 1-[2,6-bis(propan-2-yl)phenyl]-3-butyl-3-{1-[3-(3-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}urea

V009-3925 Screening compound: 1-[2,6-bis(propan-2-yl)phenyl]-3-butyl-3-{1-[3-(3-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}urea
V009-3925 Screening compound: 1-[2,6-bis(propan-2-yl)phenyl]-3-butyl-3-{1-[3-(3-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}urea alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-3925
1-[2,6-bis(propan-2-yl)phenyl]-3-butyl-3-{1-[3-(3-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-3925

Molecular Formula

C33H39ClN4O2 (C33 H39 ClN4 O2)

Compound Name

1-[2,6-bis(propan-2-yl)phenyl]-3-butyl-3-{1-[3-(3-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}urea

IUPAC name

1-[26-bis(propan-2-yl)phenyl]-3-butyl-3-{1-[3-(3-chlorophenyl)-4-oxo-34-dihydroquinazolin-2-yl]ethyl}urea

SMILES

CCCCN(C(C)C(N1c2cccc(Cl)c2)=Nc(cccc2)c2C1=O)C(Nc1c(C(C)C)cccc1C(C)C)=O

InChI

InChI=1S/C33H39ClN4O2/c1-7-8-19-37(33(40)36-30-26(21(2)3)16-12-17-27(30)22(4)5)23(6)31-35-29-18-10-9-15-28(29)32(39)38(31)25-14-11-13-24(34)20-25/h9-18,20-23H,7-8,19H2,1-6H3,(H,36,40)/t23-/m0/s1

InChI Key

IMHAAAXDRITFQP-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD01401302

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

559.15

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.301

Distribution Coefficient, logD

6.299

Water Solubility, LogSw

-6.00

Polar Surface Area

47.988

Acid Dissociation Constant (pKa)

15.64

Base Dissociation Constant (pKb)

4.63

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.40

V009-3925 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

PI3K-Targeted Library (17255 compounds)

PLpro Library (6343 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V009-3925 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-3925?
Check Price and Availability of V009-3925, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-3925 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-3925
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-3925
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-3925 available by request